Guided Therapeutics
Financial ratios & Valuation

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-2.97-0.41-0.09-0.0115.40-0.12-2.41-2.08-1.96-2.24-1.26-0.12
Price/Sales ratio
35.754.750.590.86274.5912.1931.6595.78750.1180.08381.58274.59
Price/Book Value ratio
-6.59-0.51-0.03-0.01-0.98-0.02-0.29-1.42-3.38-2.06-3.04-0.02
Price/Cash Flow ratio
-4.68-0.71-0.19-0.18-11.46-0.54-1.72-4.87-6.59-4.49-4.37-11.46
Price/Free Cash Flow ratio
-4.57-0.71-0.19-0.18-11.46-0.54-1.72-4.83-6.46-4.49-4.24-11.46
Price/Earnings Growth ratio
0.090.000.000.00-0.150.000.02-0.010.040.04-0.11-0.15
Dividend Yield
N/AN/A284.55%N/A0.74%N/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
-8.26%11.38%18.51%-117.21%-56.14%-94.44%59.80%24.69%-523.07%36.73%-260.86%-94.44%
Operating Profit Margin
-1053.34%-1027.55%-631.40%-1279.09%-2715.78%-2602.77%-1031.37%-2916.04%-25638.46%-3527.55%-19534.78%-2602.77%
Pretax Profit Margin
-1200.85%-1138.94%-656.19%-4383.60%1782.45%-5336.11%-273.52%-2555.55%-33392.30%-3560.20%-25104.34%-5336.11%
Net Profit Margin
-1200.85%-1138.94%-656.19%-4383.60%1782.45%-9391.66%-1308.82%-4601.23%-38246.15%-3560.20%-30230.43%-9391.66%
Effective Tax Rate
-5.01%-3.81%-49.44%-10.50%425.88%-76.00%-378.49%-80.04%-14.53%N/A-20.41%-20.41%
Return on Assets
-326.06%-269.29%-266.08%-2187.32%430.50%-286.52%-98.88%-182.69%-147.71%-209.04%-206.56%-286.52%
Return On Equity
221.34%124.09%42.84%55.12%-6.42%19.96%12.29%68.44%172.45%91.67%170.74%-6.42%
Return on Capital Employed
551.46%210.65%48.68%27.28%14.39%8.34%13.82%64.64%221.75%110.09%298.93%14.39%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.61N/A
Quick Ratio
0.130.180.020.000.000.070.030.180.500.150.470.00
Cash ratio
0.030.000.000.00N/A0.070.020.110.470.120.470.47
Days of Sales Outstanding
149.90114.43N/A4.4883.24131.8085.88207.28168.4626.0795.2183.24
Days of Inventory outstanding
483.38760.58572.30182.5467.52250.285.38K3.41K2.46K3.72K2.40K467.52
Operating Cycle
633.29875.02572.30186.98550.77382.095.47K3.62K2.63K3.74K2.43K550.77
Days of Payables Outstanding
709.921.23K1.92K2.07K12.35K15.81K22.56K14.65K10.02K11.90K9.61K15.81K
Cash Conversion Cycle
-76.63-364.75-1.35K-1.89K-11.80K-15.43K-17.09K-11.02K-7.38K-8.16K-8.92K-11.80K
Debt Ratios
Debt Ratio
0.870.592.709.4921.594.982.931.230.591.141.854.98
Debt Equity Ratio
-0.59-0.27-0.43-0.23-0.32-0.34-0.36-0.46-0.69-0.5-2.16-0.34
Long-term Debt to Capitalization
-0.22N/AN/AN/A-0.02-0.03-0.06-0.33-0.64-0.15-0.81-0.03
Total Debt to Capitalization
-1.46-0.37-0.77-0.31-0.47-0.53-0.57-0.86-2.32-1-1.38-0.53
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-4.78N/A
Cash Flow to Debt Ratio
-2.36-2.65-0.44-0.24-0.26-0.13-0.47-0.63-0.73-0.91-1.19-0.13
Company Equity Multiplier
-0.67-0.46-0.16-0.02-0.01-0.06-0.12-0.37-1.16-0.43-1.16-0.06
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-7.63-6.67-2.97-4.68-23.94-22.38-18.38-19.65-113.69-17.81-87.21-22.38
Free Cash Flow / Operating Cash Flow Ratio
1.021.0011111.001.001.0211.031
Cash Flow Coverage Ratio
-2.36-2.65-0.44-0.24-0.26-0.13-0.47-0.63-0.73-0.91-1.19-0.13
Short Term Coverage Ratio
-3.43-2.65-0.44-0.24-0.28-0.15-0.56-1.39-1.66-1.25-5.22-0.15
Dividend Payout Ratio
N/AN/A-25.81%N/A11.41%N/AN/AN/AN/AN/AN/AN/A